Company Filing History:
Years Active: 2019
Title: Syed Hidayathulla: Innovator in Pharmaceutical Chemistry
Introduction
Syed Hidayathulla is a notable inventor based in Riyadh, Saudi Arabia. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on sulindac derivatives. His research focuses on developing compounds that can be utilized in treating inflammation and related diseases.
Latest Patents
Syed Hidayathulla holds a patent for sulindac derivatives. These compounds are characterized by a specific formula where R represents one of twenty-five substituted or unsubstituted phenyl substituents, along with pharmaceutically acceptable salts. The synthesis of these derivatives involves refluxing sulindac hydrazide with appropriately substituted benzaldehydes in the presence of ethanol and catalytic amounts of glacial acetic acid. The sulindac derivatives are intended for use as active ingredients in pharmaceutical compositions aimed at treating inflammation or inflammatory diseases. Additionally, they may serve as analgesic and gastric sparing agents.
Career Highlights
Syed Hidayathulla is affiliated with King Saud University, where he contributes to research and development in the pharmaceutical field. His work has garnered attention for its potential applications in medicine and healthcare.
Collaborations
He collaborates with esteemed colleagues, including Mashooq Ahmad Bhat and Mohamed Abdulrahman Al-Omar, who share his commitment to advancing pharmaceutical research.
Conclusion
Syed Hidayathulla's innovative work on sulindac derivatives exemplifies the impact of research in pharmaceutical chemistry. His contributions are paving the way for new treatments in the medical field.